You are here

Immune Design

Merck to buy immunotherapy developer Immune Design for $300 million

Reuters

Thu, 02/21/19 - 09:58 am

Immune Design buries its PhIII work on cancer, and investors hit the panic button

Endpoints

Sat, 10/13/18 - 10:53 pm

Immune Design Poised on Progress of Pipeline Candidates

Yahoo/Zacks.com

Mon, 03/19/18 - 11:50 am

soft tissue sarcoma

Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma

Yahoo

Mon, 08/10/15 - 08:08 am

clinical trials

non-Hodgkin's lymphoma

7 Biotech Stocks Moving Off The UBS Healthcare Conference

Yahoo/Benzinga

Tue, 05/19/15 - 04:57 pm

Cerulean Pharma

Endo International

Esperion Therapeutics

Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy

Yahoo

Thu, 10/16/14 - 08:17 am

herpes simplex virus

Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy

Yahoo

Thu, 08/7/14 - 08:18 am

GLAAS plantform

Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships

Seeking Alpha

Sun, 10/31/10 - 11:35 am

Teva Pharmaceuticals

Pacific Biosciences

Baxter International

Amicus Therapeutics